| The centre was set up in December 1981 to provide subsidized haemodialysis (blood-washing) treatment for patients with end stage kidney failure. This was made possible by a donation from Dr. Li Ka Shing to set up the first charitable haemodialysis centre in Hong Kong. Currently, the centre has 9 haemodialysis machines to provide subsidized hameodialysis treatment for up to 54 patients. With the subsidy, the cost to patient is about $1000-1200 per dialysis treatment (pending on the amount of subsidy granted). |   |
| To meet the increasing demand for haemodialysis facility, since 1994, HKKF has operated a second dialysis centre at Wo Che Estate, Shatin. This was made possible by a generous donation from the Jockey Club Charities Trust. Currently, the centre now has 13 haemodialysis machines, with a capacity to provide treatment for up to 78 patients. |   |
Nocturnal haemodialysis at home support program
| In July 2007, in conjunction with the Hospital Authority, Hong Kong, a Nocturnal Haemodialysis program was launched for suitable patients to self perform haemodialysis treatment at home every night or alternative night. This mode of dialysis has better result than twice or thrice weekly haemodialysis. Patient can return to normal life during the day time. HKKF provides the patient with a subsidy of $3000 /month (1/3 of the cost), while HA provides a subsidy of $4000 / month and the patient has to pay around $3000 / month. |   |
| The home Automated Peritoneal Dialysis (APD) program was launched in August 1997. With donations from various organisations, HKKF purchases APD machines for free loaning to patients. The program has made it possible for patient to perform peritoneal dialysis treatment at home overnight and be free during the daytime, thus facilitate them to maintain normal life and even full time job, achieving better rehabilitation and reintegration back into the society. Currently, HKKF has 135 APD machines for free loaning to patients. |   |
Since 2002, HKKF has supported patients with kidney transplant with partial (50%) funding to purchase some of the newer anti-rejection drugs. This was made possible by the generous support from various pharmaceutical companies.
Since August 2008, HKKF has supported patient with end stage kidney failure with a 50% subsidy (approximately $800/month) to purchase EPO (a hormone to stimulate blood formation) to correct the anaemia. This was made possible by the generous support from a pharmaceutical company.
Copyright@1999. Hong Kong Kidney Foundation
Ltd. All right reserved..
Created by Tse Tak Yee 1999